BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15646749)

  • 1. Fluorodeoxyglucose F 18 positron emission tomography scanning in thoracic disease.
    Fahy RJ; King M
    South Med J; 2004 Dec; 97(12):1156-7. PubMed ID: 15646749
    [No Abstract]   [Full Text] [Related]  

  • 2. PET for the evaluation of solitary pulmonary nodules.
    Fisher RE
    J Nucl Med; 2009 Feb; 50(2):326; author reply 326-7. PubMed ID: 19164230
    [No Abstract]   [Full Text] [Related]  

  • 3. Chondroid hamartoma presenting as solitary pulmonary nodule: results of dual time point (18)F-fluorodeoxyglucose-PET and comparison with (18)F-fluorothymidine PET and histopathology.
    Basu S; Nandy S; Rajan MG; Ramadwar M; Moghe SH
    Hell J Nucl Med; 2011; 14(2):173-4. PubMed ID: 21761023
    [No Abstract]   [Full Text] [Related]  

  • 4. Growing pulmonary nodule with increased 18-fluorodeoxyglucose uptake in a former smoker.
    Tanaka R; Emerson LL; Karwande SV; Schreiber G
    Chest; 2005 May; 127(5):1848-51. PubMed ID: 15888868
    [No Abstract]   [Full Text] [Related]  

  • 5. PET evaluation of lung cancer.
    Bunyaviroch T; Coleman RE
    J Nucl Med; 2006 Mar; 47(3):451-69. PubMed ID: 16513615
    [No Abstract]   [Full Text] [Related]  

  • 6. [Isolated cavitary pulmonary nodule and positron emission tomography].
    Ukena D; Hellwig D
    Pneumologie; 2001 Jul; 55(7):357-9. PubMed ID: 11481584
    [No Abstract]   [Full Text] [Related]  

  • 7. 18Fluorodeoxyglucose positron emission tomography, a standard diagnostic tool in lung cancer.
    Giaccone G
    J Natl Cancer Inst; 2007 Dec; 99(23):1741-3. PubMed ID: 18042929
    [No Abstract]   [Full Text] [Related]  

  • 8. Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer?
    Aquino SL; Fischman AJ
    Chest; 2004 Sep; 126(3):755-60. PubMed ID: 15364753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.
    Daniels CE; Lowe VJ; Aubry MC; Allen MS; Jett JR
    Chest; 2007 Jan; 131(1):255-60. PubMed ID: 17218584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
    Bryant AS; Cerfolio RJ
    Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 62-year-old woman with PET-positive solitary pulmonary nodule.
    Saha B; Chong WH; Chieng H; Chopra A
    BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34167994
    [No Abstract]   [Full Text] [Related]  

  • 12. Imaging evaluation of the solitary pulmonary nodule: self-assessment module.
    Ko JP; Roberts CC; Berger WG; Chew FS
    AJR Am J Roentgenol; 2007 Mar; 188(3 Suppl):S1-4. PubMed ID: 19645123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography imaging in nonmalignant thoracic disorders.
    Alavi A; Gupta N; Alberini JL; Hickeson M; Adam LE; Bhargava P; Zhuang H
    Semin Nucl Med; 2002 Oct; 32(4):293-321. PubMed ID: 12524653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography.
    Herder GJ; van Tinteren H; Golding RP; Kostense PJ; Comans EF; Smit EF; Hoekstra OS
    Chest; 2005 Oct; 128(4):2490-6. PubMed ID: 16236914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.
    Lee ST; Berlangieri SU; Poon AM; Mitchell P; Pathmaraj K; Tabone K; Byrne AJ; O'Keefe GJ; Knight SR; Clarke CP; Scott AM
    Intern Med J; 2007 Nov; 37(11):753-9. PubMed ID: 17517082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Widespread tophaceous gout demonstrating avid F-18 fluorodeoxyglucose uptake.
    Steiner M; Vijayakumar V
    Clin Nucl Med; 2009 Jul; 34(7):433-4. PubMed ID: 19542948
    [No Abstract]   [Full Text] [Related]  

  • 17. Oncological applications of positron emission tomography for evaluation of the thorax.
    Kwee TC; Torigian DA; Alavi A
    J Thorac Imaging; 2013 Jan; 28(1):11-24. PubMed ID: 23249968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The value of FDG-PET/CT in the evaluation of patients with a pulmonary nodule and a previous malignant disease].
    Ben-Nun A; Orlovsky M; Best AL; Bar Shalom R
    Harefuah; 2006 Oct; 145(10):713-7, 784, 783. PubMed ID: 17111703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fleischner Lecture. Computed tomography of the thorax: current perspectives.
    Heitzman ER
    AJR Am J Roentgenol; 1981 Jan; 136(1):2-12. PubMed ID: 6779571
    [No Abstract]   [Full Text] [Related]  

  • 20. Hiatal hernia mimics centrally necrotic cancer in the lung on FDG positron emission tomographic imaging.
    Bhargava P; Zhuang H; Alavi A
    Clin Nucl Med; 2003 Apr; 28(4):347-9. PubMed ID: 12642727
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.